Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.62 USD | 0.00% | -2.01% | -44.77% |
14/05 | Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing | MT |
09/05 | Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.77% | 462M | |
+35.22% | 50.93B | |
-0.51% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+12.11% | 26.02B | |
-21.99% | 18.9B | |
+7.98% | 13.21B | |
+24.45% | 12.17B | |
+28.95% | 12.16B |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- Citigroup Initiates Coverage on Editas Medicine With Neutral Rating, $11 Price Target